ArticleFrontiers in immunology2021

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.

Darrell O RickePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.